Annual report pursuant to Section 13 and 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.24.1
Organization and Basis of Presentation (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 17, 2021
Dec. 31, 2023
Dec. 31, 2022
Nov. 20, 2023
Accumulated deficit   $ (53,400,000)    
Common stock shares, par value   $ 0.0001 $ 0.0001  
Exercise price per share       $ 2.82
Cash and cash equivalents   $ 7,400,000    
Net Cash Used In Operation   $ (6,400,000) $ (6,400,000.0)  
Warrant exercise price $ 112.00      
Warrants issued 24,106      
Initial Public Offering [Member]        
Common stock shares, par value $ 0.0001      
Warrants to purchase one share of common stock 160,714      
Sale of stock 160,714      
Exercise price per share $ 112.00      
Warrant exercise price 112.00      
Combined Offering Price $ 112.00      
Warrants issued 184,820      
Gross proceeds from warrants purchase of common stock $ 15,400,000      
Issuance costs $ 2,600,000